Efficacy of blinatumomab as maintenance therapy for B-lineage acute lymphoblastic leukemia/lymphoma following allogeneic hematopoietic cell transplantation

• Jiayu Huang,
• Bingyang Shi,
• Suhui Yu,
• Mengxing Xue,
• Ling Wang,
• Jieling Jiang,
• Jiong Hu,
• Jun Zhu,
• Suning Chen,
• Lijing Shen,
• Weijie Cao,
• Yang Cao,
• Xiaoxia Hu

Affiliations

Jiayu Huang

State Key Laboratory of Medical Genomics, Shanghai Institute of Hematology, National Research Center for Translational Medicine at Shanghai, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine

Bingyang Shi

Department of Hematology, The First Affiliated Hospital of Zhengzhou University

Suhui Yu

Department of Hematology, Renji Hospital, Shanghai Jiao Tong University School of Medicine

Mengxing Xue

National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Institute of Blood and Marrow Transplantation, Collaborative Innovation Center of Hematology, Soochow University

Ling Wang

Collaborative Innovation Center of Hematology, Shanghai Jiao Tong University School of Medicine

Jieling Jiang

Collaborative Innovation Center of Hematology, Shanghai Jiao Tong University School of Medicine

Jiong Hu

Collaborative Innovation Center of Hematology, Shanghai Jiao Tong University School of Medicine

Jun Zhu

GoBroad Medical Institute of Hematology (Shanghai Center), Liquan Hospital

Suning Chen

National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Institute of Blood and Marrow Transplantation, Collaborative Innovation Center of Hematology, Soochow University

Lijing Shen

Department of Hematology, Renji Hospital, Shanghai Jiao Tong University School of Medicine

Weijie Cao

Department of Hematology, The First Affiliated Hospital of Zhengzhou University

Yang Cao

Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology

Xiaoxia Hu

State Key Laboratory of Medical Genomics, Shanghai Institute of Hematology, National Research Center for Translational Medicine at Shanghai, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine